Table of Content - Recombinant Therapeutic Antibodies And Proteins Market

Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies are highly successful and experience unparalleled growth potential in terms of their efficacy.

Market Dynamics

Recombinant therapeutic proteins and antibodies have gained high traction in clinical applications. Due to development of antibody-based therapeutics, mammalian expression systems have experienced a major boost and microbial expression systems continue to be widely used in industries, which in turn will fuel growth of the market. However, variations in production methods of therapeutic antibodies can lead to differences in their structure, based on the selection of recombinant procedure. Most protein therapeutics available in the market are recombinant and majority of them are in clinical trials for therapy of immune disorders, cancers, infections, and other diseases. Various engineered proteins, including multi-specific fusion proteins, bi-specific monoclonal antibodies (mAbs) and mAbs conjugated small molecule drugs, and proteins with optimized pharmacokinetics are under development.

Key features of the study

This report provides in-depth analysis of recombinant therapeutic antibodies and proteins market and provides market size (USD Bn) and cumulative annual growth rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global recombinant therapeutic antibodies and proteins market based on the following parameters – company overview, financial performance, product portfolio, market presence, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbott, Amgen Inc., Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer Inc., and Sanofi S.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global recombinant therapeutic antibodies and proteins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the recombinant therapeutic antibodies and proteins market

Market Segmentation

By Drug Class (Revenue, USD Bn, 2021-2033)
- Monoclonal Antibodies
- Plasma Protein
- Growth Factors
- Fusion Proteins
- Hormones
- Enzyme
- Coagulation Factors
- Others
By Application (Revenue, USD Bn, 2021-2033)
- Oncology
- Hematology
- Immunology
- Endocrinology
- Infectious Disease
- Cardiovascular Disease
- Others
By Region (Revenue, USD Bn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Competitive Landscape
- Abbott
- Amgen Inc.
- Biogen Inc.,
- Eli Lilly and Company
- Hoffmann-La Roche
- Johnson and Johnson
- Merck & Co.
- Novo Nordisk
- Pfizer Inc.
- Sanofi S.A.

Table of Contents

Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Drug Class
Market Snippet, By Application
Market Snippet, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Market Trends
Pipeline Analysis
Drug Development Challenges
New Market Entrants
Regulatory Scenario
PEST Analysis
Porter’s Analysis

Global Recombinant Therapeutic Antibodies and Proteins Market, By Drug Class, 2021 – 2033, (USD Bn)

Introduction

Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends

Plasma Protein

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Growth Factors

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Fusion Proteins

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Monoclonal Antibodies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Hormones

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Enzyme

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Coagulation Factors

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Others

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Global Recombinant Therapeutic Antibodies and Proteins Market, By Application, 2021 – 2033, (USD Bn)

Introduction

Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends

Oncology

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Hematology

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Immunology

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Endocrinology

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Infectious Disease

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Cardiovascular Disease

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Others

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)

Global Recombinant Therapeutic Antibodies and Proteins Market, By Region, 2021 – 2033, (USD Bn)

Introduction

Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends

North America

Market Size and Forecast, By Drug Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)

U.S.
Canada

Latin America

Market Size and Forecast, By Drug Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)

Brazil
Mexico
Argentina
Rest of Latin America

Europe

Market Size and Forecast, By Drug Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

Market Size and Forecast, By Drug Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

Market Size and Forecast, By Drug Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)

GCC
Israel
Rest of Middle East

Africa

Market Size and Forecast, By Drug Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)

South Africa
Central Africa
North Africa

Competitive Landscape

Heat Map Analysis
Company Profiles

Abbott

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Amgen Inc.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Biogen Inc.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Eli Lilly and Company

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

F. Hoffmann-La Roche

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Johnson and Johnson

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Merck & Co.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Novo Nordisk

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Pfizer Inc.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Sanofi S.A.

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Analyst Views

Section

References
Research Methodology
About us and Sales Contact

*Browse 22 market data tables and 27 figures on "Recombinant Therapeutic Antibodies and Proteins Market - Global forecast to 2033”

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE